Dysferlin deficiency and the development of cardiomyopathy in a mouse model of limb-girdle muscular dystrophy 2B.
about
Ion channel macromolecular complexes in cardiomyocytes: roles in sudden cardiac deathCharacterization of dysferlin deficient SJL/J mice to assess preclinical drug efficacy: fasudil exacerbates muscle disease phenotypeNonmuscle myosin IIA facilitates vesicle trafficking for MG53-mediated cell membrane repair.Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophyInflammatory dilated cardiomyopathy in Abcg5-deficient mice.Dysferlin forms a dimer mediated by the C2 domains and the transmembrane domain in vitro and in living cells.Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient miceCardiac T-Tubule Microanatomy and Function.VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects.GRAF1 deficiency blunts sarcolemmal injury repair and exacerbates cardiac and skeletal muscle pathology in dystrophin-deficient mice.Inhibition of inflammation with celastrol fails to improve muscle function in dysferlin-deficient A/J miceDystrophin and dysferlin double mutant mice: a novel model for rhabdomyosarcomaPlasma Membrane Repair: A Central Process for Maintaining Cellular Homeostasis.Prospect of gene therapy for cardiomyopathy in hereditary muscular dystrophy.Mouse alopecia areata and heart disease: know your mouse!Mouse genome-wide association study identifies polymorphisms on chromosomes 4, 11, and 15 for age-related cardiac fibrosis.Dysferlin mediates the cytoprotective effects of TRAF2 following myocardial ischemia reperfusion injury.Dysferlin deficiency confers increased susceptibility to coxsackievirus-induced cardiomyopathy.Increased non-HDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B.Treatment with Recombinant Human MG53 Protein Increases Membrane Integrity in a Mouse Model of Limb Girdle Muscular Dystrophy 2B.
P2860
Q28087459-D155E47E-30EB-4CBA-B2DA-A6DF2D721A9AQ28475580-D1FA86FE-86CD-4FC6-A503-7B22BB6F5DC8Q30513782-45A8F30A-8D07-4C80-B7EE-CCCAC2136920Q30545559-D0E3CFBC-F05C-4492-A00B-BFE2082D6E23Q33404236-8931F369-AB32-4E2D-812A-A071E6AB3B4EQ34081840-E0B6A1D4-9D79-4872-9613-5B52DB28FAF5Q34360151-1904850D-8B28-406F-8433-27E15ECB9083Q34545692-1B2867B1-AD8E-4E3A-8EDA-4EFDCECEEB54Q34981147-6D54AC14-9D0B-4610-9AF2-D92EECE92A35Q35753474-6C6DD763-6118-44B1-BA60-8678A8780BCDQ35984257-35043D59-8A25-4310-9B65-884688604F5DQ36025454-E5C9068D-04B8-47F9-B828-84A32093E4D4Q36240722-F1F08496-87D1-4C9A-9B85-9F462AE66301Q37021623-589EAFBD-E5D2-4D4C-B005-9002BF43D10FQ37302908-006243A2-3C86-4C8D-A6E7-F110F19AA484Q37585811-AFE816D9-2226-43F6-A57A-0BBB2E7F0E7BQ37648514-3702CA78-8849-4BD7-ABA6-166296EF7EEFQ41161957-A5E7EEAB-934D-4137-AF2D-70F399382BDCQ47413106-99E395BE-4E44-4D0E-840B-5A09C7F8798AQ48020261-C00B5B05-2807-43D0-95CC-F9B91AB34A47
P2860
Dysferlin deficiency and the development of cardiomyopathy in a mouse model of limb-girdle muscular dystrophy 2B.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dysferlin deficiency and the d ...... -girdle muscular dystrophy 2B.
@en
Dysferlin deficiency and the d ...... -girdle muscular dystrophy 2B.
@nl
type
label
Dysferlin deficiency and the d ...... -girdle muscular dystrophy 2B.
@en
Dysferlin deficiency and the d ...... -girdle muscular dystrophy 2B.
@nl
prefLabel
Dysferlin deficiency and the d ...... -girdle muscular dystrophy 2B.
@en
Dysferlin deficiency and the d ...... -girdle muscular dystrophy 2B.
@nl
P2093
P2860
P1476
Dysferlin deficiency and the d ...... -girdle muscular dystrophy 2B.
@en
P2093
Gregory A Cox
Leonard D Shultz
Lisa Burzenski
Oded Foreman
Thomas H Chase
P2860
P304
P356
10.2353/AJPATH.2009.080930
P407
P577
2009-10-29T00:00:00Z